aspirin has been researched along with adenosine kinase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullough, DA; Montag, A; Mullane, KM; Young, MA; Zhang, C | 1 |
| Beitelshees, AL; Dane, A; Ellero-Simatos, S; Fiehn, O; Georgiades, A; Hankemeier, T; Horenstein, RB; Kaddurah-Daouk, R; Lewis, JP; Reijmers, T; Shuldiner, AR; Yerges-Armstrong, LM; Zhu, H | 1 |
1 trial(s) available for aspirin and adenosine kinase
| Article | Year |
|---|---|
Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.
Topics: Adenosine Kinase; Adult; Alleles; Aspirin; Drug Resistance; Female; Humans; Male; Metabolomics; Platelet Aggregation Inhibitors; Purines | 2013 |
1 other study(ies) available for aspirin and adenosine kinase
| Article | Year |
|---|---|
Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Aminoimidazole Carboxamide; Animals; Aspirin; Blood Physiological Phenomena; Coronary Thrombosis; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Erythrocytes; Humans; Male; Plasma; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Regional Blood Flow; Ribonucleosides; Theophylline; Tubercidin | 1994 |